FGEN - FibroGen, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.99B
Enterprise Value 33.64B
Trailing P/E N/A
Forward P/E 1513.67
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)19.45
Price/Book (mrq)8.14
Enterprise Value/Revenue 317.78
Enterprise Value/EBITDA 6-43.07

Trading Information

Stock Price History

Beta (3Y Monthly) 2.19
52-Week Change 3-26.69%
S&P500 52-Week Change 36.90%
52 Week High 367.85
52 Week Low 333.51
50-Day Moving Average 342.66
200-Day Moving Average 348.57

Share Statistics

Avg Vol (3 month) 3826.87k
Avg Vol (10 day) 3415.62k
Shares Outstanding 583.42M
Float 77.41M
% Held by Insiders 110.92%
% Held by Institutions 166.88%
Shares Short (Jun 28, 2019) 45.35M
Short Ratio (Jun 28, 2019) 46.58
Short % of Float (Jun 28, 2019) 47.48%
Short % of Shares Outstanding (Jun 28, 2019) 46.20%
Shares Short (prior month May 31, 2019) 44.48M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -44.14%
Operating Margin (ttm)-46.33%

Management Effectiveness

Return on Assets (ttm)-7.06%
Return on Equity (ttm)-17.61%

Income Statement

Revenue (ttm)204.9M
Revenue Per Share (ttm)2.42
Quarterly Revenue Growth (yoy)-25.30%
Gross Profit (ttm)-22.88M
EBITDA -84.58M
Net Income Avi to Common (ttm)-90.44M
Diluted EPS (ttm)-1.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)565.4M
Total Cash Per Share (mrq)6.56
Total Debt (mrq)77.14M
Total Debt/Equity (mrq)15.17
Current Ratio (mrq)6.16
Book Value Per Share (mrq)5.68

Cash Flow Statement

Operating Cash Flow (ttm)-21.7M
Levered Free Cash Flow (ttm)-5.4M